Virtus Investment Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421K Buy
11,290
+3,276
+41% +$100K 0.1% 250
2026
Q1
$267K Buy
8,014
+195
+2% +$6.54K 0.07% 301
2025
Q4
$270K Buy
7,819
+2,712
+53% +$86.5K 0.07% 291
2025
Q3
$139K Buy
5,107
+887
+21% +$21.5K 0.04% 390
2025
Q2
$88.7K Sell
4,220
-2,148
-34% -$41.2K 0.03% 389
2025
Q1
$104K Buy
+6,368
New +$136K 0.03% 414

Other funds holding IDYA

Virtus Investment Advisers's IDYA Position: Q2 2026 in Review

Virtus Investment Advisers increased its IDEAYA Biosciences (IDYA) stake by 41% in Q2 2026, buying an estimated $100K and bringing the position to 11,290 shares worth $421K. The position accounts for 0.1% of the portfolio, ranked #250.

Virtus Investment Advisers first reported a position in IDYA in Q1 2025 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Virtus Investment Advisers held 11,290 shares of IDEAYA Biosciences worth $421K as of Q2 2026.
  • Virtus Investment Advisers bought 3,276 IDEAYA Biosciences shares in Q2 2026, an estimated $100K.
  • IDEAYA Biosciences made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #250 holding.
  • Virtus Investment Advisers first reported a position in IDEAYA Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.